197 related articles for article (PubMed ID: 34468272)
1. Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic.
Sorsa T; Sahni V; Buduneli N; Gupta S; Räisänen IT; Golub LM; Lee HM; Pätilä T; Bostanci N; Meurman J; Pärnänen P; Nwhator SO; Singla M; Gauba K
Expert Rev Proteomics; 2021 Aug; 18(8):707-717. PubMed ID: 34468272
[TBL] [Abstract][Full Text] [Related]
2. The Ability of Quantitative, Specific, and Sensitive Point-of-Care/Chair-Side Oral Fluid Immunotests for aMMP-8 to Detect Periodontal and Peri-Implant Diseases.
Alassiri S; Parnanen P; Rathnayake N; Johannsen G; Heikkinen AM; Lazzara R; van der Schoor P; van der Schoor JG; Tervahartiala T; Gieselmann D; Sorsa T
Dis Markers; 2018; 2018():1306396. PubMed ID: 30154936
[TBL] [Abstract][Full Text] [Related]
3. Active MMP-8 point-of-care (PoC)/chairside enzyme-test as an adjunctive tool for early and real-time diagnosis of peri-implantitis.
Lähteenmäki H; Tervahartiala T; Räisänen IT; Pärnänen P; Mauramo M; Gupta S; Sampson V; Rathnayake N; Heikkinen AM; Alassiri S; Gieselmann DR; Frankenberger R; Sorsa T
Clin Exp Dent Res; 2022 Apr; 8(2):485-496. PubMed ID: 35118828
[TBL] [Abstract][Full Text] [Related]
4. Active Matrix Metalloproteinase-8 (aMMP-8) Versus Total MMP-8 in Periodontal and Peri-Implant Disease Point-of-Care Diagnostics.
Räisänen IT; Aji NRAS; Sakellari D; Grigoriadis A; Rantala I; Pätilä T; Heikkilä P; Gupta S; Sorsa T
Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001886
[TBL] [Abstract][Full Text] [Related]
5. aMMP-8 point-of-care - diagnostic methods and treatment modalities in periodontitis and peri-implantitis.
Lähteenmäki H; Pätilä T; Pärnänen CP; Räisänen I; Tervahartiala T; Gupta S; Sorsa T
Expert Opin Ther Targets; 2023; 27(7):627-637. PubMed ID: 37522314
[TBL] [Abstract][Full Text] [Related]
6. Validation of a noninvasive aMMP-8 point-of-care diagnostic methodology in COVID-19 patients with periodontal disease.
Gupta S; Mohindra R; Singla M; Khera S; Kumar A; Rathnayake N; Sorsa T; Pfützner A; Räisänen IT; Soni RK; Kanta P; Jain A; Gauba K; Goyal K; Singh MP; Ghosh A; Kajal K; Mahajan V; Suri V; Bhalla A
Clin Exp Dent Res; 2022 Aug; 8(4):988-1001. PubMed ID: 35818743
[TBL] [Abstract][Full Text] [Related]
7. Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines.
Sorsa T; Tervahartiala T; Leppilahti J; Hernandez M; Gamonal J; Tuomainen AM; Lauhio A; Pussinen PJ; Mäntylä P
Pharmacol Res; 2011 Feb; 63(2):108-13. PubMed ID: 20937384
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of aMMP-8 and azurocidin in peri-implant sulcular fluid as biomarkers of peri-implant health or disease.
Xanthopoulou V; Räisänen IT; Sorsa T; Tortopidis D; Sakellari D
Clin Exp Dent Res; 2024 Jun; 10(3):e883. PubMed ID: 38853451
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of active matrix metalloproteinase-8 point-of-care test for the discrimination of periodontal health status: Comparison of saliva and oral rinse samples.
Deng K; Wei S; Xu M; Shi J; Lai H; Tonetti MS
J Periodontal Res; 2022 Aug; 57(4):768-779. PubMed ID: 35575900
[TBL] [Abstract][Full Text] [Related]
10. Salivary Diagnostics-Point-of-Care diagnostics of MMP-8 in dentistry and medicine.
Rathnayake N; Gieselmann DR; Heikkinen AM; Tervahartiala T; Sorsa T
Diagnostics (Basel); 2017 Jan; 7(1):. PubMed ID: 28117682
[TBL] [Abstract][Full Text] [Related]
11. Host-Modulation Therapy and Chair-Side Diagnostics in the Treatment of Peri-Implantitis.
Sorsa T; Bacigalupo J; Könönen M; Pärnänen P; Räisänen IT
Biosensors (Basel); 2020 Apr; 10(5):. PubMed ID: 32344881
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of collagenase-2 from gingival crevicular fluid and peri-implant sulcular fluid in periodontitis and peri-implantitis patients: pilot study.
Xu L; Yu Z; Lee HM; Wolff MS; Golub LM; Sorsa T; Kuula H
Acta Odontol Scand; 2008 Aug; 66(4):219-24. PubMed ID: 18615324
[TBL] [Abstract][Full Text] [Related]
13. Active matrix metalloproteinase-8 and interleukin-6 detect periodontal degeneration caused by radiotherapy of head and neck cancer: a pilot study.
Keskin M; Lähteenmäki H; Rathnayake N; Räisänen IT; Tervahartiala T; Pärnänen P; Şenışık AM; Karaçetin D; Yentek Balkanay A; Heikkilä P; Hagström J; Rautava J; Haglund C; Gursoy UK; Silbereisen A; Bostanci N; Sorsa T
Expert Rev Proteomics; 2020 Oct; 17(10):777-784. PubMed ID: 33406924
[No Abstract] [Full Text] [Related]
14. On the diagnostic discrimination ability of mouthrinse and salivary aMMP-8 point-of-care testing regarding periodontal health and disease.
Räisänen IT; Heikkinen AM; Nwhator SO; Umeizudike KA; Tervahartiala T; Sorsa T
Diagn Microbiol Infect Dis; 2019 Dec; 95(4):114871. PubMed ID: 31473032
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-8 levels in oral samples as a biomarker for periodontitis in the Chinese population: an observational study.
Yuan C; Liu X; Zheng S
BMC Oral Health; 2018 Mar; 18(1):51. PubMed ID: 29587716
[TBL] [Abstract][Full Text] [Related]
16. aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases.
Sorsa T; Nwhator SO; Sakellari D; Grigoriadis A; Umeizudike KA; Brandt E; Keskin M; Tervahartiala T; Pärnänen P; Gupta S; Mohindra R; Bostanci N; Buduneli N; Räisänen IT
Front Oral Health; 2022; 3():897115. PubMed ID: 35757444
[TBL] [Abstract][Full Text] [Related]
17. Matrix Metalloproteinase-8 as an Inflammatory and Prevention Biomarker in Periodontal and Peri-Implant Diseases.
Al-Majid A; Alassiri S; Rathnayake N; Tervahartiala T; Gieselmann DR; Sorsa T
Int J Dent; 2018; 2018():7891323. PubMed ID: 30305812
[TBL] [Abstract][Full Text] [Related]
18. Periodontal disease and targeted prevention using aMMP-8 point-of-care oral fluid analytics in the COVID-19 era.
Räisänen IT; Umeizudike KA; Pärnänen P; Heikkilä P; Tervahartiala T; Nwhator SO; Grigoriadis A; Sakellari D; Sorsa T
Med Hypotheses; 2020 Nov; 144():110276. PubMed ID: 33254580
[TBL] [Abstract][Full Text] [Related]
19. aMMP-8 Point-of-Care/Chairside Oral Fluid Technology as a Rapid, Non-Invasive Tool for Periodontitis and Peri-Implantitis Screening in a Medical Care Setting.
Lähteenmäki H; Umeizudike KA; Heikkinen AM; Räisänen IT; Rathnayake N; Johannsen G; Tervahartiala T; Nwhator SO; Sorsa T
Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32764436
[TBL] [Abstract][Full Text] [Related]
20. Applicability of an active matrix metalloproteinase-8 point-of-care test in an oral and maxillofacial surgery clinic: a pilot study.
Kallio E; Puolakkainen T; Tervahartiala T; Snäll J; Marttila E; Sorsa T; Uittamo J
Odontology; 2024 Jan; 112(1):250-255. PubMed ID: 37249720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
